Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2019 14
2020 11
2021 12
2022 5
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: an updated systematic review and meta-analysis.
Tsuboi I, Matsukawa A, Parizi MK, Klemm J, Mancon S, Chiujdea S, Fazekas T, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Wada K, Araki M, Shariat SF. Tsuboi I, et al. Among authors: iwata t. World J Urol. 2024 Apr 23;42(1):252. doi: 10.1007/s00345-024-04941-2. World J Urol. 2024. PMID: 38652324 Free PMC article.
A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Klemm J, Mancon S, Chiujdea S, Fazekas T, Miszczyk M, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Karakiewicz P, Wada K, Rouprêt M, Araki M, Shariat SF. Tsuboi I, et al. Among authors: iwata t. Eur Urol Oncol. 2024 Apr 3:S2588-9311(24)00083-X. doi: 10.1016/j.euo.2024.03.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38575408 Free article. Review.
Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changes.
Tominaga Y, Kobayashi T, Matsumoto Y, Moriwake T, Oshima Y, Okumura M, Horii S, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Sugimoto M, Kobayashi Y, Watanabe M, Namba Y, Matsumoto Y, Nakatsuka M, Araki M. Tominaga Y, et al. Among authors: iwata t. Andrology. 2024 Apr 2. doi: 10.1111/andr.13640. Online ahead of print. Andrology. 2024. PMID: 38563871
The current status and novel advances of boron neutron capture therapy clinical trials.
Zhou T, Igawa K, Kasai T, Sadahira T, Wang W, Watanabe T, Bekku K, Katayama S, Iwata T, Hanafusa T, Xu A, Araki M, Michiue H, Huang P. Zhou T, et al. Among authors: iwata t. Am J Cancer Res. 2024 Feb 15;14(2):429-447. doi: 10.62347/HBBE6868. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455422 Free PMC article. Review.
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab.
Katayama S, Iwata T, Kawada T, Okamoto Y, Sano Y, Kawago Y, Miyake S, Moriwake T, Kuinose A, Horikawa Y, Tsuboi K, Tsuboi I, Sakaeda K, Nakatsuka H, Takamoto A, Hirata T, Shirasaki Y, Yamasaki T, Morinaka H, Nagasaki N, Hara T, Ochi A, Okumura M, Watanabe T, Sekito T, Kawano K, Horii S, Yamanoi T, Nagao K, Yoshinaga K, Maruyama Y, Tominaga Y, Sadahira T, Nishimura S, Edamura K, Kobayashi T, Kusumi N, Kurose K, Yamamoto Y, Sugimoto M, Nakada T, Sasaki K, Takenaka T, Ebara S, Miyaji Y, Wada K, Kobayashi Y, Araki M. Katayama S, et al. Among authors: iwata t. Urol Oncol. 2024 Mar;42(3):70.e11-70.e18. doi: 10.1016/j.urolonc.2023.11.009. Epub 2023 Dec 20. Urol Oncol. 2024. PMID: 38129282
47 results